title: How many CIN2+ lesions can be avoided through HPV 16/18 vaccination?
authors.forename: Frank
authors.initials: F
authors.lastname: Hulstaert
authors.forename: Chris
authors.initials: C
authors.lastname: De Laet
mesh_terms: D002584:Cervix Uteri / Q000601:surgery / Q000821:virology; D005260:Female; D013509:Gynecologic Surgical Procedures / Q000009:adverse effects; D052162:Human papillomavirus 16; D052161:Human papillomavirus 18; D006801:Humans; D030361:Papillomavirus Infections / Q000517:prevention & control* / Q000601:surgery; D053918:Papillomavirus Vaccines; D011247:Pregnancy; D047928:Premature Birth / Q000517:prevention & control*; D002578:Uterine Cervical Dysplasia / Q000517:prevention & control* / Q000601:surgery
chemical_list: D053918:Papillomavirus Vaccines